Biodesix BDSX Cash Flow Statement (2019-2026)

NASDAQ BDSX
$28.52 -2.08 (-6.80%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Biodesix Quarterly Cash Flow Statement

Periods 28 quarters
Latest Jun 2026

Biodesix reported cash from operations of -$1.56M and free cash flow of -$0.44M for the quarter ended Jun 2026, up 76.2% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-14.64M-13.18M-15.60M-12.97M-13.65M-16.44M-18.76M-13.36M-9.56M-9.20M-13.55M-10.17M-10.63M-8.40M-10.82M-11.62M-9.12M-4.03M-8.18M-7.37M
Share-based CompensationStock Comp.
2.87M1.27M2.94M2.87M2.71M2.08M2.80M2.56M2.07M1.08M3.67M4.03M4.02M1.26M6.53M6.86M0.33M1.07M1.11M0.73M
Gains from Investment SecuritiesGains Investment
1.00M-0.06M1.39M-0.06M0.38M-0.10M
Asset Writedowns and ImpairmentWritedown
0.40M0.14M0.30M0.07M0.20M0.17M0.10M-0.27M0.07M0.07M0.10M0.07M0.03M0.01M0.00M0.02M0.01M
Cash from OperationsCash from Ops.
-7.79M-10.20M-13.10M-9.59M-10.33M-11.95M-7.69M0.94M-3.84M-12.28M-15.31M-18.57M-10.67M-4.10M-8.60M-6.57M-8.88M0.78M-10.17M-1.56M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.28M0.45M0.77M0.75M0.76M0.63M0.46M0.33M
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.80M0.85M0.91M0.90M0.89M0.90M0.79M0.78M0.78M0.98M1.42M1.41M1.49M1.45M1.44M1.44M1.41M1.39M1.40M1.39M
Change in Working Capital
Change in ReceivablesChange Receivables
-2.50M0.87M0.08M1.68M-0.99M0.74M0.03M-0.61M1.76M3.54M2.34M0.33M-1.86M1.00M-0.90M-0.18M5.22M-3.61M0.49M-0.29M
Change in Accured ExpensesChange Accured Exp.
0.19M1.84M-1.30M0.11M0.55M-0.13M-2.03M3.27M-1.48M0.76M-1.23M0.56M0.62M1.69M-1.94M2.34M0.49M0.97M-2.34M0.77M
Other Working Capital ChangesOther WC Changes
-1.07M1.18M0.17M-0.86M-1.18M0.66M-0.54M-0.81M-0.45M0.89M0.42M-1.55M0.35M0.06M-0.21M-0.10M2.33M-1.76M1.37M-2.18M
Investing Activities
Capital ExpendituresCapex
0.96M0.53M-0.47M-0.47M4.58M-0.14M7.68M6.42M5.84M2.98M0.23M1.93M0.23M0.84M0.07M0.05M0.05M0.09M0.08M-1.12M
Cash from Investing ActivitiesCash from Investing
-1.04M-0.64M-0.35M-0.38M-0.81M-1.99M-7.71M-6.47M-5.88M-3.00M-0.27M-2.00M-0.29M-0.88M-0.14M-0.10M-0.07M-0.10M-0.14M-0.25M
Financing Activities
Other financing activitiesOther financing
0.06M0.03M0.07M0.02M0.06M0.12M-0.03M0.12M-0.21M-0.06M-0.07M-0.08M-0.13M-0.17M-0.20M0.28M-0.17M-0.26M1.25M-1.56M
Cash from Financing ActivitiesCash from Financing
0.40M-4.36M-2.83M22.13M-2.27M41.85M-2.42M-2.33M12.15M21.73M0.79M51.30M0.14M-0.18M0.10M9.79M4.82M1.71M16.90M6.24M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.00M0.23M0.38M0.34M0.45M1.70M2.41M2.44M0.16M0.30M
Net Equity Issued and RepurchasedNet Equity Issued
1.60M2.90M1.80M41.57M15.30M12.20M0.62M55.00M5.00M2.32M17.21M6.70M
Additional items
Change in Cash
-8.44M-15.20M-16.29M12.16M-13.41M27.91M-17.81M-7.87M2.43M6.44M-14.79M30.73M-10.81M-5.16M-8.64M3.13M-4.12M2.38M6.58M4.42M
Free Cash FlowFCF
-8.75M-10.73M-12.63M-9.13M-14.91M-11.81M-15.36M-5.48M-9.68M-15.27M-15.54M-20.50M-10.90M-4.93M-8.68M-6.62M-8.93M0.69M-10.25M-0.44M
Net Cash FlowNCF
-8.44M-15.20M-16.29M12.16M-13.41M27.91M-17.81M-7.87M2.43M6.44M-14.79M30.73M-10.81M-5.16M-8.64M3.13M-4.12M2.38M6.58M4.42M